CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...

Big Issue is powering-up our Driving Change For Good partnership with Citroën, by helping our wider social enterprise family with access to electric vehicles ...

W hen the puck dropped on the Professional Women’s Hockey League last January 1, diehard fans were cautiously optimistic.

CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...

Ionis Pharmaceuticals (IONS) announced the pivotal Phase 3 study design following successful alignment with the U.S. FDA on ION582, an investigational medicine for the treatment of people living ...

Agios expects to report topline results from this 52-week Phase 3 study in late 2025. Sickle cell disease is an inherited, lifelong blood disorder caused by mutations in hemoglobin, the major ...

BioNTech (NASDAQ:BNTX) and OncoC4 have had a partial clinical hold placed by the FDA on a Phase 3 study for their drug candidate BNT316/ONC-392 in the treatment of non-small cell lung cancer ...

The coming months may be interesting as the company moves closer to Phase 3 data. Analyst target of $15 implies over 1,000% upside; I maintain a Buy rating despite near-term financing ...

The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing varying results among patients. The hold impacts an open-label trial ...

The U.S. Space Force has awarded two task orders worth $733.6 million combined to SpaceX to provide Lane 1 launch services as part of the third phase of the National Security Space Launch program.

Otsuka Pharmaceutical’s kidney disease drug has hit the primary endpoint of a phase 3 trial by demonstrating in an interim analysis the reduction of patients’ urine protein-to-creatine ratio ...

Credit: Space Force The U.S. Space Force has tapped SpaceX for the first two launch service orders under its new National Security Space Launch (NSSL) Phase 3 Lane 1 approach, the service ...